Can You Get Withdrawals From Mounjaro? (October 2026)

01 · The short answer

Do you get withdrawals from Mounjaro?

Tirzepatide has a half-life of about five days, and after a final dose it takes roughly 4–5 weeks to clear the system.¹ There is no way to speed this up, and nothing needs doing while it clears.

The medicine works by activating two gut-hormone receptors, GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.¹ It follows that once the medicine has cleared, it is no longer doing that work. Many people notice this as feeling hungrier or less full after meals. That is the medicine wearing off, which is different from the body reacting to the loss of a dependence-forming substance.

If you notice new symptoms after stopping that worry you, speak to your prescriber. You can also report them through the MHRA Yellow Card scheme.¹⁹

02 · The decision you are facing

Stop, pause or carry on: what to decide

Most people reading this are weighing one of three choices: stop completely, take a break, or keep going on a dose that works. The right answer depends on your goals, your tolerance of the medicine and your health. It is a conversation for your prescriber, not something to settle by guesswork.

Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition. It is used alongside a reduced-calorie diet and increased physical activity.¹¹¹ If you are thinking of stopping because of side effects, cost or a plateau, tell your prescriber first. There may be options short of stopping. Our guide on getting the most from treatment covers the practical habits that sit alongside the injection.

If you are on treatment with us, your monthly reviews are the natural place to raise this. Aftercare includes ongoing reviews, dose titration and side-effect support from the prescribing team, and repeat orders re-check suitability. There is no auto-shipping, so nothing is sent unless you reorder.

03 · Cost planning

What continuing costs

Cost is one common reason people consider stopping, so it helps to see it clearly. The Mounjaro pen costs £169.99 per month at the 2.5mg starting dose, with all six doses in stock. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) come to £959.96 at standard prices. A first year of 13 pens costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. These are standard prices before discounts. A new customer's first order is £40 less with code FIRST40, and every later order is £25 less (code DOSE25). Prices checked 10 October 2026.

Ordering with us takes four steps. First, complete a free online consultation. Second, a GPhC-registered prescriber reviews it. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, our registered pharmacy dispenses it, with same-day dispatch when ordered by 3pm. Fourth, free next-day tracked delivery arrives in temperature-controlled packaging. You can start your free consultation here, or see the full Mounjaro ordering page.

04 · What withdrawal means

What "withdrawal" means with Mounjaro

When people ask about withdrawals, they usually mean one of two different things. The first is a withdrawal reaction, where the body has adapted to a substance and reacts when it is removed. The second is simply the return of the problem the medicine was treating. These are not the same, and mixing them up causes a lot of worry.

The UK patient leaflet does not list a withdrawal syndrome for Mounjaro.

Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1. Together they help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.¹ In practice, most people on treatment feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

Because those effects come from the medicine being present, they are not kept going once it has cleared your system. That is the plain logic behind why stopping can feel different. The appetite support you had while on treatment is no longer being supplied, so the hunger signals you had before treatment can reassert themselves. It is a loss of the medicine's effect, not a reaction to losing a habit-forming drug.

This distinction matters for what you do next. A true withdrawal reaction would call for medical supervision of the stopping process. A fading appetite effect calls for something different: planning your eating, your routine and your follow-up before your last dose rather than after it. Your prescriber can help you think this through.

If someone tells you precisely what will happen to you after stopping, they are claiming more certainty than the evidence supports.

If you feel unwell after stopping, do not assume it is related or unrelated. Contact your prescriber, and if you wish, report it through the Yellow Card scheme so that it is recorded.¹⁹ Related questions about feeling unwell on treatment are covered in our guide to feeling sick on Mounjaro.

05 · How long it takes to clear

How long Mounjaro takes to leave your system

Mounjaro takes roughly 4–5 weeks to clear your system after your final dose. That comes from tirzepatide's half-life of about five days.¹ A half-life is the time it takes for the amount of medicine in the body to fall by half, so the level drops gradually rather than switching off on the day of your last injection.

This has a practical consequence. If you stop injecting, you will not feel the full change straight away. Because the medicine is still present and still active in the first weeks, many people find the effect fades slowly rather than stopping abruptly.

There is no way to speed this up, and nothing needs doing while it clears. You do not need a special diet, supplement or procedure to flush the medicine out. If you see dramatic claims about detoxing or accelerating clearance, treat them with scepticism.

The slow clearance also explains why timing matters if you have an upcoming event, a planned procedure or a pregnancy plan. If any of these apply, speak to your prescriber well in advance, because the medicine will still be in your system for several weeks after the final injection. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Those need individual medical advice.

A simple way to picture it is in stages. While you are still injecting weekly, the medicine is present and working. After your last dose, the amount in your body falls over roughly 4–5 weeks. After that, it has cleared. Your appetite, your digestion and your blood sugar then reflect your body without the medicine, which is where your eating habits and any other treatment matter most.

If you have type 2 diabetes, keep your diabetes team involved before you stop. Your blood sugar management may need to be reviewed as the medicine clears, and that is a conversation for your prescriber or diabetes clinic, not a decision to make alone.

One more point on timing. Because the half-life is about five days and the schedule is once weekly, the licensed pattern is designed around weekly dosing.

06 · Hunger and food noise

Hunger, cravings and "food noise" after stopping

Hunger and cravings can come back as Mounjaro clears, because the appetite-regulating effect of the medicine is no longer present. This is the most commonly discussed change after stopping, and it follows directly from how the medicine works.

Tirzepatide activates GIP and GLP-1 receptors, which help regulate appetite and slow how quickly the stomach empties.¹ While you are on treatment, most people feel fuller sooner and less hungry between meals. Once the medicine has cleared, those two effects are no longer being supplied. The practical result for many people is that meals feel less filling and snacking feels harder to resist.

"Food noise" is a popular term for persistent thoughts about food. It does not mean something has gone wrong, and it does not mean you have failed.

It does help to plan for it. Some practical ideas that sit within general healthy-eating advice, rather than medicine-specific claims:

• Decide in advance what a normal day of meals looks like, so you are not deciding while hungry.
• Keep the habits you built on treatment, such as regular meal times and mindful portion sizes.
• Keep up the physical activity you added. Treatment is designed to be used alongside increased activity.
• Tell your prescriber if hunger becomes hard to manage, so you can discuss options together.

It is worth being clear that none of this is a promise about what you will experience. Some people notice a strong return of appetite, others notice less.

If your hunger returns and you decide you want to continue, that is a decision to make with your prescriber rather than by restarting on your own. Restarting involves choosing a suitable dose, and that depends on your circumstances.

If stopping was because of side effects rather than choice, say so at your review.

07 · Weight after stopping

Weight after stopping Mounjaro

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

As a worked example, for someone starting at 100 kg, 15% is about 15 kg and 20.9% is about 21 kg. That is straight arithmetic of the trial percentages, not a prediction for you. Trial averages do not predict your own result.

That trial describes weight lost during treatment. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average; stopping should always be planned with your prescriber.¹⁴ So the habits that matter on treatment are the same habits that matter afterwards.

If your aim is to keep weight off, think about what you can control:

• Eating pattern. Keep a reduced-calorie approach you can sustain, rather than a short-term crash plan.
• Activity. Continue the increased physical activity that treatment is designed to be used with.
• Monitoring. Weighing yourself regularly, or using the free GLPTrackr companion app, can help you notice changes early and talk to your prescriber sooner.
• Support. Ask your prescriber about follow-up rather than disappearing after your last dose.

Finally, if you are weighing up stopping because progress has slowed, our guide to getting the most from Mounjaro covers practical changes worth trying before you decide.

08 · Breaks and restarting

Taking a week off, stretching doses and restarting

Do not change the schedule yourself. Mounjaro is a once-weekly injection, and decisions about skipping, delaying or restarting belong with your prescriber. This matters because several of the most common questions on this topic, such as taking a week off, injecting every 10 days or restarting after a three-week break, are about changing the licensed pattern.

Taking a week off. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time. If more than 4 days have passed, skip the missed dose and take the next one on your normal day. Never take two doses within 3 days of each other.¹³ Do not take a double dose to make up for a missed dose.

Injecting every 10 days. The licensed schedule is once weekly.¹ Stretching the gap between doses, sometimes called dose stretching, is off-label use. If you are considering it because of cost or side effects, tell your prescriber so they can discuss options that stay within the licence.

Restarting after a break. After a gap of several weeks, you may no longer have meaningful medicine in your system. Tirzepatide takes roughly 4–5 weeks to clear.¹ This is exactly what a prescriber review is for. They will consider how long you have been off, what dose you were on, how you tolerated it and your current health.

If you order with us, repeat orders re-check suitability and there is no auto-shipping, so nothing is dispatched without you asking. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

A few safe, general principles apply whatever your situation:

• Never use another person's pen or a pen from an unofficial source.
• Do not take extra injections to catch up.
• Keep your prescriber informed about any gap in treatment.
• Check the leaflet and keep it with your pens.

If you want the right dose after a long gap, speak to the prescriber who knows your history. The aim is to avoid guessing.

09 · Side effects and long-term safety

Side effects, long-term safety and what to report

If you are worried about side effects or about symptoms after stopping, your prescriber can discuss them with you, and the patient leaflet lists them in full.¹¹³

For symptoms that you are not sure about, the right approach is consistent. A symptom that is not on the leaflet list is not a listed side effect. Then speak to your prescriber about any new symptom, listed or not, and report it through the MHRA Yellow Card scheme.¹⁹ Reports help regulators spot patterns, and they take seconds to submit.

Several specific concerns come up often, and we have separate pages for them:

• Gallstones and Mounjaro
• Blood clots and Mounjaro
• Cancer questions and Mounjaro
• Dizziness on Mounjaro
• Feeling sick on Mounjaro

It helps to know when to seek urgent help. For severe stomach pain or any symptom you think is an emergency, get medical help straight away rather than waiting for a pharmacy reply. Use NHS urgent services in those situations.

A note on feeling unwell right after stopping. Because the medicine is still present for roughly 4–5 weeks after the final dose, a symptom in the first weeks may still be related to the medicine being in your system. Equally, it may be unrelated. A prescriber, GP or pharmacist can help you work out which.

If you are on other medicines, keep your prescriber informed when you start, stop or change Mounjaro. If you take medicines for type 2 diabetes, discuss any plan to stop with the clinician managing your diabetes, because the right treatment plan may change.

Finally, our ongoing support includes side-effect support from the prescribing team, so you do not have to work this out alone. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413.

10 · Who is Mounjaro for

Eligibility: who Mounjaro is licensed for

Knowing who the medicine is for helps when you are deciding whether to continue, stop or restart. Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition. Qualifying conditions include high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes.¹¹¹ It must be used alongside a reduced-calorie diet and increased physical activity.

A prescriber will assess your BMI, medical history and current medicines before deciding whether it is suitable for you. This is not a one-off tick-box. It matters again when you return after a break, because your weight, health and medicines may have changed.

That is also why a restart is a prescribing decision. Your BMI may now be lower than when you began, and whether treatment is still appropriate depends on your individual circumstances and the prescriber's judgement.

In terms of how it is described, Mounjaro is a once-weekly injectable prescription medicine made by Eli Lilly, supplied as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

The medicine also has a licence for type 2 diabetes. If you take it for diabetes, stopping has different implications from stopping a weight-management course, and your diabetes team should be part of any decision.

As for the reasons people stop, they vary. Some reach their goal, some find side effects hard, some run into cost, and some simply want a break. None of those is a wrong reason. What matters is that the decision is informed and that someone qualified knows about it.

Good questions to bring to your prescriber:

• If I stop, what should I watch for in the following weeks?
• What eating and activity plan suits me afterwards?
• If I want to restart later, how will that be handled?
• Should I step down my dose or simply stop?

Your prescriber can advise on whether stepping down before stopping suits you.

11 · NHS versus private

NHS and private routes if you want to continue or return

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition. The NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years.

That is relevant to stopping and restarting. If you are on NHS-supplied treatment, speak to the NHS clinician managing it before you stop, because the route back may depend on local service arrangements.

If you are treated privately, the pathway is different. A free online consultation is reviewed by a GPhC-registered prescriber, and unsuitable orders are refunded automatically. Supply comes through official LillyDirect channels, meaning Mounjaro direct from Eli Lilly's UK distribution, with genuine KwikPens and all six doses stocked from 2.5mg to 15mg.

Many people who meet the licensed criteria choose regulated private treatment rather than waiting for NHS access. Whether that suits you is a personal decision, and it should be informed by cost as well as clinical need. See the Mounjaro pen product page for the live prices. Those prices come with a new-customer discount on first orders and a reorder discount on every future order, with current values and codes shown on the page.

A safety note applies to anyone looking to return to treatment from an unofficial source. Counterfeit and unregulated weight-loss injections exist, and the MHRA publishes alerts about them.⁷ Be wary of anyone offering to supply without a consultation or prescription. Genuine Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. You can verify a pharmacy on the GPhC register; ours is registration 9012878.

Payment options include Visa and Mastercard, Klarna and pay-monthly options, with no subscriptions. The consultation is free, the price shown is the price paid, and there are no hidden fees. Delivery is free next-day tracked, in temperature-controlled discreet packaging, and Saturday delivery costs £14.99.

Our overview of weight loss treatments sets out the range of options available through us, and your prescriber can advise on which suit you.

12 · Switching and alternatives

Switching to another treatment instead of stopping

Stopping is not the only alternative to carrying on. Some people switch to a different medicine, and that is a prescriber decision. Our guide to switching from Mounjaro to Wegovy covers that direction in detail.

To understand the difference in broad terms, tirzepatide activates two gut-hormone receptors, GIP and GLP-1, which is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide.¹ Wegovy (semaglutide) pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly. Titration steps up after at least 4 weeks, reaching the 2.4mg maintenance dose from week 17.¹⁸ The 2.4mg dose is the licensed maintenance dose for weight management.

Notice what that means for switching. A new medicine usually starts at its own lowest dose and works up, so a switch is not like-for-like. It is a new course with its own schedule, which is why it needs a prescriber's judgement rather than a self-made plan.

Liraglutide, supplied as Saxenda and in other products, is a daily injection at a concentration of 6mg per millilitre, unlike once-weekly Mounjaro and Wegovy. Your prescriber can advise on how it compares.

Newer oral options also exist, including Wegovy tablets and Foundayo. For current availability of the tablets, see our weight loss treatments page.

Be cautious about supplements marketed as natural alternatives to prescription injections. Dramatic weight-loss claims on such products deserve scepticism.

The questions to ask yourself before switching are simple. Why am I changing? What did I like or dislike about my current treatment? What will my prescriber need to know? If you are changing because of side effects, say which ones. If because of cost, say so. The more your prescriber knows, the better the advice you will get.

Whatever you choose, treatment works alongside a reduced-calorie diet and increased physical activity. Those habits are the common thread across every option, and they are the part you keep control of at every stage.

13 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹